| Interferon‐α/β–mediated innate immune mechanisms in dermatomyositis SA Greenberg, JL Pinkus, GS Pinkus, T Burleson, D Sanoudou, R Tawil, ... Annals of Neurology: Official Journal of the American Neurological …, 2005 | 653 | 2005 |
| Clinical spectrum of chronic acquired demyelinating polyneuropathies DS Saperstein, JS Katz, AA Amato, RJ Barohn Muscle & Nerve: Official Journal of the American Association of …, 2001 | 526 | 2001 |
| Distal acquired demyelinating symmetric neuropathy JS Katz, DS Saperstein, G Gronseth, AA Amato, RJ Barohn Neurology 54 (3), 615-615, 2000 | 373 | 2000 |
| Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis–Sumner syndrome DS Saperstein, AA Amato, GI Wolfe, JS Katz, SP Nations, CE Jackson, ... Muscle & Nerve: Official Journal of the American Association of …, 1999 | 304 | 1999 |
| Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder JS Katz, GI Wolfe, PB Andersson, DS Saperstein, JL Elliott, SP Nations, ... Neurology 53 (5), 1071-1071, 1999 | 194 | 1999 |
| Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics GI Wolfe, NS Baker, AA Amato, CE Jackson, SP Nations, DS Saperstein, ... Archives of neurology 56 (5), 540-547, 1999 | 180 | 1999 |
| Challenges in the identification of cobalamin-deficiency polyneuropathy DS Saperstein, GI Wolfe, GS Gronseth, SP Nations, LL Herbelin, ... Archives of neurology 60 (9), 1296-1301, 2003 | 170 | 2003 |
| Axonal multifocal motor neuropathy without conduction block or other features of demyelination JS Katz, RJ Barohn, S Kojan, GI Wolfe, SP Nations, DS Saperstein, ... Neurology 58 (4), 615-620, 2002 | 137 | 2002 |
| A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis M Pasnoor, J He, L Herbelin, TM Burns, S Nations, V Bril, AK Wang, ... Neurology 87 (1), 57-64, 2016 | 131 | 2016 |
| International Guillain‐Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in … BC Jacobs, B van den Berg, C Verboon, G Chavada, DR Cornblath, ... Journal of the Peripheral Nervous System 22 (2), 68-76, 2017 | 126 | 2017 |
| Pilot trial of etanercept in the treatment of inclusion-body myositis RJ Barohn, L Herbelin, JT Kissel, W King, AL McVey, DS Saperstein, ... Neurology 66 (1_suppl_1), S123-S124, 2006 | 111 | 2006 |
| Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy RJ Barohn, DS Saperstein Seminars in neurology 18 (01), 49-61, 1998 | 100 | 1998 |
| Diagnosis of mast cell activation syndrome: a global “consensus-2” LB Afrin, MB Ackerley, LS Bluestein, JH Brewer, JB Brook, AD Buchanan, ... Diagnosis 8 (2), 137-152, 2021 | 93 | 2021 |
| Management of myasthenia gravis DS Saperstein, RJ Barohn Seminars in neurology 24 (01), 41-48, 2004 | 90 | 2004 |
| Progressive muscular atrophy T Liewluck, DS Saperstein Neurologic clinics 33 (4), 761-773, 2015 | 86 | 2015 |
| A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS PH Gordon, YK Cheung, B Levin, H Andrews, C Doorish, RB Macarthur, ... Amyotrophic Lateral Sclerosis 9 (4), 212-222, 2008 | 84 | 2008 |
| Phase I clinical trial of safety of L-serine for ALS patients TD Levine, RG Miller, WG Bradley, DH Moore, DS Saperstein, LE Flynn, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18 (1-2), 107-111, 2017 | 71 | 2017 |
| Routine use of punch biopsy to diagnose small fiber neuropathy in fibromyalgia patients TD Levine, DS Saperstein Clinical rheumatology 34, 413-417, 2015 | 68 | 2015 |
| Peripheral neuropathy due to cobalamin deficiency DS Saperstein, RJ Barohn Current treatment options in neurology 4, 197-201, 2002 | 68 | 2002 |
| Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis Q Gang, C Bettencourt, PM Machado, S Brady, JL Holton, AM Pittman, ... Neurobiology of Aging 47, 218. e1-218. e9, 2016 | 57 | 2016 |